CY1106913T1 - Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος - Google Patents

Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος

Info

Publication number
CY1106913T1
CY1106913T1 CY20071101280T CY071101280T CY1106913T1 CY 1106913 T1 CY1106913 T1 CY 1106913T1 CY 20071101280 T CY20071101280 T CY 20071101280T CY 071101280 T CY071101280 T CY 071101280T CY 1106913 T1 CY1106913 T1 CY 1106913T1
Authority
CY
Cyprus
Prior art keywords
derivatives
group
syndrome
therapeutic
azabicyclo
Prior art date
Application number
CY20071101280T
Other languages
English (en)
Inventor
S Yamazaki
Original Assignee
Dynogen Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynogen Pharmaceuticals, Inc. filed Critical Dynogen Pharmaceuticals, Inc.
Publication of CY1106913T1 publication Critical patent/CY1106913T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Abstract

Ένα νέο προληπτικό και/ή θεραπευτικό φάρμακο δια το σύνδρομο της φλογώσεως των εντέρων που επικρατεί της δυσκοιλιότητος (IBS) το οποίον περιλαμβάνει ως δραστικό συστατικό ένα παράγωγο θειένο [3,2-β] πυριδινοκαρβοξαμίδης που παριστάνεται από τον τύπο (Ι):
CY20071101280T 2001-08-24 2007-10-08 Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος CY1106913T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001254662 2001-08-24
EP02705169A EP1419772B1 (en) 2001-08-24 2002-03-14 Preventive agent/remedial agent for constipation predominant ibs

Publications (1)

Publication Number Publication Date
CY1106913T1 true CY1106913T1 (el) 2012-09-26

Family

ID=19082790

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101280T CY1106913T1 (el) 2001-08-24 2007-10-08 Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος

Country Status (13)

Country Link
US (2) US20040248927A1 (el)
EP (2) EP1419772B1 (el)
JP (1) JPWO2003018012A1 (el)
KR (1) KR100869759B1 (el)
CN (1) CN1545412A (el)
AT (2) ATE367813T1 (el)
CA (1) CA2457053C (el)
CY (1) CY1106913T1 (el)
DE (2) DE60221402T2 (el)
DK (1) DK1419772T3 (el)
ES (1) ES2289086T3 (el)
PT (1) PT1419772E (el)
WO (1) WO2003018012A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
SE0401578D0 (sv) 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
US20080269276A1 (en) * 2007-02-12 2008-10-30 Dynogen Pharmaceuticals, Inc. Compositions useful for treating irritable bowel syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
JP3250921B2 (ja) * 1994-11-21 2002-01-28 三菱化学株式会社 腸管運動機能不全性疾患の治療剤
JPH08286450A (ja) 1995-04-19 1996-11-01 Matsushita Electric Ind Co Ltd 画像読取り等複合装置
NZ518579A (en) * 1999-11-23 2003-09-26 Janssen Pharmaceutica Nv Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease

Also Published As

Publication number Publication date
ATE421323T1 (de) 2009-02-15
EP1419772A1 (en) 2004-05-19
DE60221402D1 (de) 2007-09-06
ES2289086T3 (es) 2008-02-01
DK1419772T3 (da) 2007-11-12
DE60231017D1 (de) 2009-03-12
EP1419772B1 (en) 2007-07-25
US20070004770A1 (en) 2007-01-04
CN1545412A (zh) 2004-11-10
CA2457053C (en) 2010-10-26
KR20040047774A (ko) 2004-06-05
EP1829543A1 (en) 2007-09-05
DE60221402T2 (de) 2008-04-03
ATE367813T1 (de) 2007-08-15
EP1419772A4 (en) 2004-11-24
US7897614B2 (en) 2011-03-01
JPWO2003018012A1 (ja) 2004-12-09
CA2457053A1 (en) 2003-03-06
EP1829543B1 (en) 2009-01-21
KR100869759B1 (ko) 2008-11-21
US20040248927A1 (en) 2004-12-09
PT1419772E (pt) 2007-09-05
WO2003018012A1 (fr) 2003-03-06

Similar Documents

Publication Publication Date Title
RU2095062C1 (ru) Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены
GEP20053475B (en) Arylmethyl-Carbonylamino-Thiazole Derivatives, and Their Use as Antitumor Agents
IL107426A (en) 3-HALO-8-ARALKOXY (OR ARALKYLAMINO) IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
PT1311272E (pt) Novos métodos utilizando inibidores de colinesterase
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
MY130755A (en) Colchinol derivatives as vascular damaging agents
TNSN05080A1 (en) NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published)
EA200601418A1 (ru) ПРОИЗВОДНЫЕ 1Н-ТИЕНО [2,3-с] ПИРАЗОЛА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ИСПОЛЬЗОВАНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
JP2004501964A5 (el)
RU2004131680A (ru) Производные бензофурана
AU755402B2 (en) Method of treating impotence due to spinal cord injury
CY1106913T1 (el) Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος
IE782084L (en) Quinolylguanidine derivatives
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
US20030078273A1 (en) Compounds for the treatment of addictive disorders
NO985063D0 (no) Pyridyl- og pyrimidyl-piperaziner i behandlig av substansmisbruks forstyrrelser
IE63194B1 (en) Antiemesis ergoline derivatives
KR910016331A (ko) 허혈성 질환 치료제
NO975811L (no) Ny anvendelse for pyrrolderivater
JP2772814B2 (ja) 記憶障害改善剤
WO2004091621A1 (en) Alternating treatment of cancer with topoisomerase i and topoisomerase ii inhibitors